| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 09/29/2011 | US20110236425 Anthrax vaccine formulation and uses thereof |
| 09/29/2011 | US20110236424 Treating allergy with detoxified e. coli heat-labile enterotoxin |
| 09/29/2011 | US20110236422 Variants of hepatitis b virus with resistance to anti-viral nucleoside agents and applications thereof |
| 09/29/2011 | US20110236421 Flavivirus host range mutations and uses thereof |
| 09/29/2011 | US20110236420 Bluetongue virus recombinant vaccines and uses thereof |
| 09/29/2011 | US20110236419 Recombinant cdv compositions and uses thereof |
| 09/29/2011 | US20110236418 Materials and Methods for Improved Vaccination |
| 09/29/2011 | US20110236417 Vaccines comprising mutant attenuated influenza viruses |
| 09/29/2011 | US20110236416 Foot and mouth disease virus recombinant vaccines and uses thereof |
| 09/29/2011 | US20110236415 Virulent oncolytic herpes simplex virus strains engineered to counter the innate host response |
| 09/29/2011 | US20110236414 Bacterial Polysaccharide-Polypeptide Conjugate Compositions |
| 09/29/2011 | US20110236412 Method for Preserving Polypeptides Using a Sugar and Polyethyleneimine |
| 09/29/2011 | US20110236411 MHC Multimers in Tuberculosis Diagnostics, Vaccine and Therapeutics |
| 09/29/2011 | US20110236410 Klebsiella antigens |
| 09/29/2011 | US20110236409 Overlapping peptides from variable antigens, t cell populations and uses thereof |
| 09/29/2011 | US20110236408 Respiratory synctial virus (rsv) sequences for protein expression and vaccines |
| 09/29/2011 | US20110236406 Immunogenic compositions comprising hmgb1 polypeptides |
| 09/29/2011 | US20110236404 Methods for Protein Expression in Mammalian Cells in Serum-Free Medium |
| 09/29/2011 | US20110236401 Compositions and methods for modulating lymphocyte activity |
| 09/29/2011 | US20110236398 Antibody Formulation |
| 09/29/2011 | US20110236393 Monoclonal antibody production in b cells and uses therof |
| 09/29/2011 | US20110236392 Composition and method for treatment of preterm labor |
| 09/29/2011 | US20110236385 Blocking mesothelin peptide fragments |
| 09/29/2011 | US20110236382 Immunosuppressive combination and its use in the treatment or prophylaxis of insulin-producing cell graft rejection |
| 09/29/2011 | US20110236380 Ligands that bind il-13 |
| 09/29/2011 | US20110236362 NKT CELL-DERIVED iPS CELLS AND NKT CELLS DERIVED THEREFROM |
| 09/29/2011 | US20110236357 Bone marrow-derived mesenchymal stem cells as a source of neural progenitors |
| 09/29/2011 | US20110236352 PEGylation by the Dock and Lock (DNL) Technique |
| 09/29/2011 | US20110236346 Compositions and Methods for Treatment of Radiation Exposure |
| 09/29/2011 | US20110236345 Composition and methods for eliciting an immune response |
| 09/29/2011 | US20110236306 Compositions and methods for the removal of biofilms |
| 09/29/2011 | US20110236304 Structural variants of antibodies for improved therapeutic characteristics |
| 09/29/2011 | CA2794483A1 Vista regulatory t cell mediator protein, vista binding agents and use thereof |
| 09/29/2011 | CA2794006A1 (20s)-2-methylene-19-nor-22-dimethyl-1.alpha.,25-dihydroxyvitamin d3 and (20r)-2-methylene-19-nor-22-dimethyl-1.alpha.,25-hydroxyvitamin d3 |
| 09/29/2011 | CA2793085A1 Anti-allergic agent |
| 09/29/2011 | CA2789200A1 Pharmaceutically active disubstituted triazine derivatives |
| 09/29/2011 | CA2786402A1 Pyrrolopyrazine derivatives and their use as jak and syk inhibitors |
| 09/28/2011 | EP2368910A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 09/28/2011 | EP2368899A1 Avian influenza vaccine |
| 09/28/2011 | EP2368886A1 Novel compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (ROR gamma, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune desease |
| 09/28/2011 | EP2368577A2 Methods for treating interleukin-6 related diseases |
| 09/28/2011 | EP2368575A2 Dry formulation for transcutaneous immunization |
| 09/28/2011 | EP2368574A1 Allergen peptide fragments and use thereof |
| 09/28/2011 | EP2368564A1 Pharmaceutical composition for acute phase protein targeted treatment of acute and chronic dysregulated inflammatory diseases or conditions |
| 09/28/2011 | EP2368431A1 Immunostimulatory G,U-containing oligoribonucleotides |
| 09/28/2011 | EP2367570A2 Antibodies to il-6 and use thereof |
| 09/28/2011 | EP2367550A1 Il-3 inhibitors in use for treatment of rheumatoid arthritis in an early stage |
| 09/28/2011 | EP2133335B1 Sphingosine compound, method for producing the same, and sphingomyelinase inhibitor |
| 09/28/2011 | EP1421191B1 Humanised antibodies specific for both CD45RB and CD45RO |
| 09/28/2011 | EP1263965B1 Avirulent, immunogenic flavivirus chimeras |
| 09/28/2011 | EP1237891B1 Heterocyclic dihydropyrimidines as potassium channel inhibitors |
| 09/28/2011 | EP1161562B9 Deleted sequences in m. bovis bcg/m. bovis or m. tuberculosis, method for detecting mycobacteria using said sequences and vaccines |
| 09/28/2011 | CN1907350B Composition, extract thereof and its pharmaceutical use |
| 09/28/2011 | CN1344159B Combinations for treatment of diseases involving angiogenesis |
| 09/28/2011 | CN102203118A Peptide antagonist of interleukin-15 activity |
| 09/28/2011 | CN102203110A Trehalose compound, method for producing same, and pharmaceutical product containing the compound |
| 09/28/2011 | CN102203101A Pyrrolo [2, 3-c] pyridine derivatives as p38 kinase inhibiting agents |
| 09/28/2011 | CN102203096A Compounds that expand hematopoietic stem cells |
| 09/28/2011 | CN102203095A Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases |
| 09/28/2011 | CN102203083A Compounds and compositions as kinase inhibitors |
| 09/28/2011 | CN102202662A Agent for treatment of diabetes |
| 09/28/2011 | CN102202653A Nanoparticles for immunotherapy |
| 09/28/2011 | CN102202519A Method for producing lipid |
| 09/28/2011 | CN102199513A Oxidation resistant health wine |
| 09/28/2011 | CN102199226A Method for extracting peanut polysaccharides from hot pressed peanut meal |
| 09/28/2011 | CN102199216A New dendritic cell co-stimulatory molecules |
| 09/28/2011 | CN102199202A Gene of recombinant fungal immunomodulatory protein between ganodermas, protein coded thereby, and application thereof |
| 09/28/2011 | CN102199201A Recombinant fungal immunomodulatory protein gene in Ganoderma lucidum, protein coded whereby and application thereof |
| 09/28/2011 | CN102199152A Heterocycle imidazoles phosphatide kinases inhibitor |
| 09/28/2011 | CN102198231A Method for extracting ceramide-rich lipid from byproducts of agriculture and forestry by supercritical extraction technology |
| 09/28/2011 | CN102198222A Medicament for treating anaphylactoid purpura |
| 09/28/2011 | CN102198218A Radix hedysari and cordyceps compound fine flour capsule and preparation method thereof |
| 09/28/2011 | CN102198170A Skin protecting composition and product |
| 09/28/2011 | CN102198155A Production method of pig spleen transfer factor injection |
| 09/28/2011 | CN102198124A Gromwell extract for treating rheumatoid arthritis, and soft capsules thereof |
| 09/28/2011 | CN102198115A Enteric-coated micro-capsule prepared by mixing traditional Chinese medicine extract and probitics |
| 09/28/2011 | CN102198097A Emulsion type nasal spray containing ciclesonide, and application thereof |
| 09/28/2011 | CN102198082A Micelle loaded with Tacrolimus or pharmaceutical salts thereof, lyophilized preparation as well as preparation methods and applications |
| 09/28/2011 | CN102197863A Chitosanoligosaccharide capsule |
| 09/28/2011 | CN101961363B Preparation method of active pseudo-ginseng slices |
| 09/28/2011 | CN101891738B Dasatinib polymorph and preparation method and medical composition thereof |
| 09/28/2011 | CN101849889B Fragrance-lasting natural essential oil nanoemulsion used for cosmetology and SPA (essential oil therapy) and preparation method thereof |
| 09/28/2011 | CN101843718B Chinese medicament for treating lupus erythematosus |
| 09/28/2011 | CN101829145B Elk horn active site and preparation method and application thereof |
| 09/28/2011 | CN101816739B Chinese medicinal composition and preparation method thereof |
| 09/28/2011 | CN101785836B Traditional Chinese medicine ointment, preparation method and application thereof for skin disease treatment |
| 09/28/2011 | CN101653425B Arbidol hydrochloride medicament composition dispersible tablets and preparation method thereof |
| 09/28/2011 | CN101649303B Bifidobacterium, application thereof and food composition containing same |
| 09/28/2011 | CN101632646B Olopatadine hydrochloride tablet as well as preparation method and detecting method thereof |
| 09/28/2011 | CN101518621B Dendrobium nobile lindl capsule capable of resisting oxidation and enhancing immunity |
| 09/28/2011 | CN101491563B Ginseng and pilose antler oral preparation and preparation method thereof |
| 09/28/2011 | CN101461894B Medicament composition for treating female climacteric syndrome and delaying age |
| 09/28/2011 | CN101433620B Longan water-soluble active substance as well as extraction method and use thereof |
| 09/28/2011 | CN101428057B Antimicrobial powder for reinforcing immune, strengthening the body resistance and removing toxicity for livestock and poultry |
| 09/28/2011 | CN101411727B Formula of pine pollen essence tablet and preparation technique thereof |
| 09/28/2011 | CN101390869B Use of high-purity forsythin in preparing bacteriostasis, antivirus medicine |
| 09/28/2011 | CN101385750B Preparation method of effective ingredient of isatis root |
| 09/28/2011 | CN101307094B Novel nuclear factor -kappa B p65 subunit antagonizing polypeptide |
| 09/28/2011 | CN101167788B Quality control method of traditional Chinese medicine 'zhenqi fuzheng' containing glossy privet fruit and radix astragali for strengthening the body resistance for aeipathia deficiency damage and qi |
| 09/27/2011 | US8026273 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient |